CELLNTEC
Live / Applied — Statement of use — registration review complete (as of 26 Mar 2026)
What this means for you
Not registered yet, but its 15 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98271320
- Mark type
- Stylized text
- Filed
- 15 Nov 2023
- Published for opposition
- 14 Jan 2025
- Attorney of record
- Michael T. Smith
Goods and services
- Class 042 — Scientific and technological services: Research, development, and testing of new medical and therapeutic products; Reseach, development, and testing of in-vitro cell structures and related products
- Class 044 — Medical, beauty and agricultural services: Blood bank and human tissue bank services; Medical services for diagnostic and treatment purposes
Owner
- CELLnTEC advanced cell systems AG, Bern, CH
- CELLnTEC advanced cell systems AG, Bern, CH
Prosecution history
- 26 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Sept 2025 — USE AMENDMENT FILED
- 14 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 11 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jan 2025 — PUBLISHED FOR OPPOSITION
- 08 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Dec 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Sept 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED